Role of oxidative damage in the pathogenesis of viral infections of the nervous system

Histology and Histopathology

Volumn 20, Issue 3, 2005, Pages 957-967

  Valyi Nagy, T ^a   Dermody, Terence S ^b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain; Lipid peroxidation; Nervous system; Oxidative damage; Oxidative stress; Viral pathogenesis; Virus

Indexed keywords

ALPHA TOCOPHEROL; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; INTERLEUKIN 1ALPHA; MALONALDEHYDE; NITRIC OXIDE; PEROXYNITRITE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; THROMBOCYTE ACTIVATING FACTOR; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA; XANTHINE OXIDASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIOXIDANT ACTIVITY; CENTRAL NERVOUS SYSTEM INFECTION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; ENZYME ACTIVATION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; LIPID PEROXIDATION; MEASLES VIRUS; MURINE LEUKEMIA VIRUS; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; REOVIRUS; REVIEW; SUBACUTE SCLEROSING PANENCEPHALITIS; VIRUS CELL INTERACTION; VIRUS ENCEPHALITIS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS REPLICATION;

HUMANS; MODELS, BIOLOGICAL; NERVOUS SYSTEM; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VIRUS DISEASES;

ALPHAVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS; MEASLES VIRUS; MURINE LEUKEMIA VIRUS; REOVIRUS SP.;

EID: 21644464144     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Adamson D.C., Kopnisky K.L., Dawson T.M. and Dawson V.L. (1999). Mechanisms and structural determinants of HIV-1 coat protein, gp41-induced neurotoxicity. J. Neurosci. 19, 64-71.
2. Adler H., Beland J.L., Del-Pan N.C., Kobzik L., Brewer J.P., Martin T.R. and Rimm I.J. (1997). Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J. Exp. Med. 185, 1533-1540.
3. Akaike T. (2001). Role of free radicals in viral pathogenesis and mutation. Rev. Med. Virol. 11, 87-101.
4. Akaike T., Noguchi Y., Ijiri S., Setoguchi K., Suga M., Zheng Y.M., Dietzschold B. and Maeda H. (1996). Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. Proc. Natl. Acad. Sci. USA 93, 2448-2453.
5. Akaike T., Suga M. and Maeda H. (1998). Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO. Proc. Soc. Exp. Biol. Med. 217, 64-73.
6. Baringer J.R. and Pisani P. (1994). Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann. Neurol. 36, 823-829.
7. Beck M.A. (2000). Nutritionally induced oxidative stress: effect on viral disease. Am. J. Clin. Nutr. 71, 1676S-1679S.
8. Boven L.A, Gomes L., Hery C., Gray F., Verhoef J., Portegies P., Tardieu M. and Nottet H.S. (1999). Increased peroxynitrite activity in AIDS dementia complex: implications for neuropathogenesis of HIV-1 infection. J. Immunol. 162, 4319-4327.
9. Buka S.L., Tsuang M.T., Torrey E.F., Klebanoff M.A., Bernstein D. and Yolken R.H. (2001). Maternal infections and subsequent psychosis among offspring. Arch. Gen. Psychiatry 58, 1032-1037.
10. Bukrinsky M.I., Nottet H.S., Schmidtmayerova H., Dubrovsky L, Flanagan C.R., Mullins M.E., Lipton S.A. and Gendelman H.E. (1995). Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181, 735-745.
11. Camandola S., Poli G. and Mattson M.P. (2000). The lipid peroxidation product 4-hydroxy-2, 3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons. Brain Res. Mol. Brain Res. 85, 53-60.
12. Cantin E.M., Hinton D.R., Chen J. and Openshaw H. (1995). Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69, 4898-4905.
13. Croen D. (1993). Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91, 2446-2452.
14. Dickerson F.B., Boronow J.J., Stallings C., Origoni A.E., Cole S., Krivogorsk B. and Yolken R.H. (2004). Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biol Psychiatry 15, 588-593.
15. Eaton P., Li J., Hearse D.J. and Shattock M.J. (1999). Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic heart. Am. J. Physiol. Heart Circ. Physiol. 276, H935-H943.
16. Everall I.P., Heaton RX, Marcotte T.D., Ellis R.J., McCutchan J.A., Atkinson J.H., Grant I., Mallory M. and Masliah E. (1999). Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group Neurobehavioral Research Center. Brain Pathol. 2, 209-217.
17. Everall I.P., Luthert P.J. and Lantos P.L. (1991). Neuronal loss in the frontal cortex in HIV infection. Lancet 337, 1119-1121.
18. Everall I.P., Luthert PJ, Lantos PL. (1993). Neuronal number and volume alterations in the neocortex of HIV infected individuals. J. Neurol. Neurosurg. Psychiatry 56, 481-486.
19. Forrest J.C. and Dermody T.S. (2003). Reovirus receptors and pathogenesis. J. Virol. 77, 9109-9115.
20. Frank J., Pompella A. and Biesalski H.K. (2002). Immunohistochemical detection of protein oxidation. In: Methods in molecular biology. Vol. 196: Oxidants and antioxidants: ultrastructure and molecular biology protocols. Armstrong D. (ed). Humana Press. Totowa, NJ, pp 35-46.
21. Fujii S., Akaike T. and Maeda H. (1999). Role of nitric oxide in the pathogenesis of herpes simplex virus encephalitis in rats. Virology 256, 203-212.
22. Fujioka N., Ohashi K., Ikeda M. and Kurimoto M. (2000). Autocrine interferon-beta stimulation augments nitric oxide production by mouse macrophage J774A.1 cells infected with herpes simplex virus type 1. Microbiol. Immunol. 44, 283-287.
23. Halliwell B. and Gutteridge J.M. (1999). Free radicals in biology and medicine. Third ed. Oxford Univ Press. Oxford.
24. Halliwell B. and Whiteman M. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Brit. J. Pharmacol. 142, 231-255.
25. Hartley D.P., Kroll D.J. and Petersen D.R. (1997). Pro-oxidant-initiated lipid peroxidation in isolated rat hepatocytes: Detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem. Res. Toxicol. 10, 895-905.
26. Haughey N.J., Cutler R.G., Tamara A., McArthur J.C., Vargas D.L., Pardo C.A., Turchan J., Nath A. and Mattson M.P. (2004). Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia. Ann. Neuro. 55, 257-267.
27. Hayashi M., Arai N., Satoh J, Suzuki H., Katayama K., Tamagawa K. and Morimatsu Y. (2002). Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J. Child Neurol. 17, 725-730.
28. Hayes M.P., Saito K., Lackner A., Wiley C.A., Achim C.L. and Markey S.P. (1998). Sources of neurotoxic quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J. 12, 881-896.
29. Itzhaki R.F., Lin W.R., Shang D., Wilcock G.K., Faragher B. and Jamieson G.A. (1997). Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349, 241-244.
30. Ji C., Rouzer C.A., Marnett L.J. and Pietenpol J.A. (1998). Induction of cell cycle arrest by the endogenous product of lipid peroxidation, malondialdehyde. Carcinogenesis 19, 1275-1283.
31. Ji C., Amarnath V., Pietenpol J.A. and Marnett L.J. (2001). 4-hydroxynonenal induces apoptosis via caspase-3 activation and cytochrome c release. Chem. Res. Toxicol. 14, 1090-1096.
32. Johnson M. and Valyi-Nagy T. (1998). Expanding the clinicopathological spectrum of herpes simplex encephalitis. Human Pathol. 29, 207-209.
33. Kakishita H. and Hattori Y. (2001). Vascular smooth muscle cell activation and growth by 4-hydroxynonenal. Life Sci. 69, 689-697.
34. Kalyankrishna S., Parmentier J.H. and Malik K.U. (2002). Arachidonic acid-derived oxidation products initiate apoptosis in vascular smooth muscle cells. Prostaglandins Other Lipid Mediat. 70, 13-29.
35. Karupiah G., Chen J.H., Mahalingam S., Nathan C.F. and MacMicking J.D. (1998). Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188, 1541-1546.
36. Keller J.N. and Mattson M.P. (1998). Roles of lipid peroxidation in modulation of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev. Neurosci. 9, 105-116.
37. Krivine A., Force G., Servan J., Cabee A., Rozenberg F., Dighiero L., Marguet F. and Lebon P. (1999). Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex. J. Neurovirol. 5, 500-506.
38. Knight J.A. (1995). Diseases related to oxygen-derived free radicals. Ann. Clin. Lab. Sci. 25, 111-126.
39. Koprowski H., Zheng Y.M., Heber-Katz E., Fraser N., Rorke L., Fu Z.F., Hanlon C. and Dietzschold B. (1993). In vivo expression of inducible nitric oxide synthetase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90, 3024-3027.
40. Kreil T.R. and Eibl M.M. (1996). Nitric oxide and viral infection: no antiviral activity against flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection of in vivo. Virology 219, 304-306.
41. Kruman I., Bruce-Keller I., Bredesden D., Waeg G. and Mattson M.P. (1997). Evidence that 4 hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17, 5089-5100.
42. Liao S.L., Raung S.L. and Chen C.J. (2002). Japanese encephalitis virus stimulates superoxide dismutase activity in rat glial cultures. Neurosci. Lett. 324, 133-136.
43. Lin R.N., Liao C.L and Lin Y.L. (2004). Replication-incompetent virions of Japanese encephalitis virus trigger neuronal death by oxidative stress in a culture system. J. Gen. Viro.l 85, 521-533.
44. Liochev S.I. and Fridovich I. (1997). How does superoxide dismutase protect against tumor necrosis factor: a hypothesis informed by effect of superoxide on free iron. Free Radic. Biol. Med. 23, 668-671.
45. Lopez-Guerrero J.A. and Alonso M.A. (1997). Nitric oxide production induced by herpes simplex virus type 1 does not alter the course of the infection in human monocytic cells. J. Gen. Virol. 78, 1977-1980.
46. Lorch S., Lightfoot R., Ohshima H., Virag L., Chen Q., Hertkorn C., Weiss M., Souca J., Ischiropoulos H., Yermilov V., Pignatelli B., Masuda M. and Szabo C. (2002). Detection of peroxynitrite-induced protein and DNA modifications. In: Methods in molecular biology. Vol. 196: Oxidants and antioxidants: ultrastructure and molecular biology protocols. Armstrong D (ed). Humana Press. Totowa, NJ, pp 247-275.
47. Love S. and Jenner P. (1999). Oxidative stress in neurological disease. Introduction. Brain Pathol. 9, 55-56.
48. Love S. and Wiley C.A. (2002). Viral diseases. In: Greenfield's neuropathology. Vol. 2. Graham D.I. and Lantos P.L. (eds). Arnold. London, New York, New Delhi, pp 1-105.
49. MacLean A., Wei X.Q., Huang F.P., Al-Alem U.A., Chan W.L. and Liew F.Y. (1998). Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J. Gen. Virol. 79, 825-830.
50. Matthews N., Neale M.L., Jackson S.K. and Stark J.M. (1987). Tumour cell killing by tumour necrosis factor: inhibition by anaerobic conditions, free radical scavengers and inhibitors of arachidonate metabolism. Immunology 62, 153-155.
51. Mesliah E., Achim C.L., Ge N., DeTeresa R., Terry R.D. and Wiley C.A. (1992). Spectrum of human immunodeficiency virus-associated neocortical damage. Ann. Neurol. 32, 321-329.
52. Meyding-Lamade U., Hass J., Lamade W., Stingele K., Kehm R., Fath A., Heinrich K., Storch Hagenlocher B. and Wildemann B. (1998). Herpes simplex virus encephalitis: long-term comparative study of viral load and the expression of immunologic nitric-oxide synthetase in mouse brain tissue. Neurosci. Lett. 244, 9-12.
53. Milatovic D., Zhang Y., Olson S.J., Montine K.S., Roberts L.J., Morrow J.D., Dermody T.S., Montine T.J. and Valyi-Nagy T. (2002). Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4 neuroprostanes. J. Neurovirol. 8, 297-307.
54. Mollace V., Nottet H.S., Clayette P., Turco M.C., Muscoll C., Salvemini D. and Perno C.F. (2001). Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 24, 411-416.
55. Montine K.S., Kim P.J., Olson S.J., Markesbery W.R. and Montine T.J. (1997). 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J. Neuropathol. Exp. Neurol. 56, 866-871.
56. Montine K.S., Olson S.J., Amarnath V., Whetsell W.O., Graham D.G. and Montine T.J. (1997). Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150, 437-443.
57. Montine K.S., Reich E., Neely M.D., Sidell K.R., Olson S.J., Markesbery W.R. and Montine T.J. (1998). Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J. Neuropathol. Exp. Neurol. 57, 415-425.
58. Morrison L.A., Sidman R.L. and Fields B.N. (1991). Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc. Natl. Acad. Sci. USA 88, 3852-3856.
59. Morrow J.D. and Roberts LJ. (1997). The isoprostanes: unique bioactive products of lipid peroxidation. Prog. Lipid Res. 36, 1-21.
60. Nath A. (2002). Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186 (Suppl 2), S193-S198.
61. Nibert M.L. and Schiff LA. (2001). Reoviruses and their replication. In: Fields virology. Knipe D.M. and Howley P.M. (eds). Lippincott, Philadelphia. pp 1679-1728.
62. Oberhaus S.M., Smith R.L., Clayton G.H., Dermody T.S. and Tyler K.L. (1997). Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J. Virol. 71, 2100-2106.
63. O'Donnell S.M., Hansberger M.W. and Dermody T.S. (2003). Viral and cellular determinants of apoptosis induced by mammalian reovirus. Int. Rev. Immunol. 22, 477-503.
64. Oster S., Christoffersen P., Gundersen H.J., Nielsen J.O., Pedersen C. and Pakkenberg B. (1995). Six billion neurons lost in AIDS. A stereological study of the neocortex. APMIS 103, 525-529.
65. Palu G., Biasolo M.A., Sartor G., Masotti L., Papini E., Floreani M. and Palatini P. (1994). Effects of herpes simplex virus type 1 infection on the plasma membrane and related functions of HeLa S3 cells. J. Gen. Virol. 75, 3337-3344.
66. Perry S.W., Hamilton J.A., Tjoelker L.W, Dbaibo G., Dzenko K.A., Epstein L.G., Hannun Y., Whittaker J.S., Dewhurst S. and Gelbard H.A. (1998). Platelet-activating factor receptor activation. An initial step in HIV-1 pathogenesis. J. Biol. Chem. 273, 17660-17664.
67. Peterhans E. (1997a). Reactive oxygen species and nitric oxide in viral diseases. Biol. Trace Elem. Res. 56, 107-116.
68. Peterhans E. (1997b). Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation. J. Nutr. 127, 962S-965S.
69. Poli G. and Schaur R.J. (2000). 4-hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 50, 315-321.
70. Pulliam L., Zhou M., Stubblebine M. and Bitler C.M. (1998). Differential modulation of cell death proteins in human brain cells by tumor necrosis factor alpha and platelet activating factor. J. Neurosci. Res. 54, 530-538.
71. Reyes M.G., Faraldi F., Senseng C.S., Flowers C. and Fariello R. (1991). Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol. 82, 39-44.
72. Roberts L.J., Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D. and Morrow J.D. (1998). Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J. Biol. Chem. 273, 13605-13612.
73. Roizman B. and Knipe D.M. (2001). Herpes simplex viruses and their replication. In: Fields virology. Knipe D.M. and Howley P.M. (eds). Lippincott Raven Press. Philadelphia. pp 2399-2460.
74. Rostasy K., Monti L., Yiannoutosos C., Kneissl M., Kemper T.L., Hedreen J.C. and Navia B.A. (1999). Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: pathogenic relationship to the acquired immunodeficiency syndrome dementia complex. Ann. Neurol. 46, 207-216.
75. Sanchez-Alcazar J.A., Schneider E., Martinez M.A., Carmona P., Hernandez-Munoz I., Siles E., De La Torre P., Ruiz-Cabello J., Garcia I. and Solis-Herruzo J.A. (2000). Tumor necrosis factor-alpha increases the steady-state reduction of cytochrome b of the mitochondrial respiratory chain in metabolically inhibited L929 cells. J. Biol. Chem. 275, 13353-13361.
76. Sanders V.J., Felisan S., Wadell A. and Tourtelotte W.W. (1996). Detection of Herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J. Neurovirol. 2, 249-258.
77. Schwarz K.B. (1996). Oxidative stress during viral infection: a review. Free Rad. Biol. Med. 21, 641-649.
78. Shimeld C., Whiteland J.L., Williams N.A., Easty D.L and Hill T.J. (1997). Cytokine production in the nervous system of mice during acute and latent infection with herpes simplex virus type 1. J. Gen. Virol. 78, 3317-3325.
79. Soh Y., Jeong K.S., Lee I.J., Bae M.A., Kim Y.C. and Song B.J. (2000). Selective activation of the c-Jun N-terminal protein kinase pathway during 4-hydroxynonenal-induced apoptosis of PC12 cells. Mol. Pharmacol. 58, 535-541.
80. Speir E. (2000). Cytomegalovirus gene regulation by reactive oxygen species. Agents of atherosclerosis. Ann. NY Acad. Sci. 899, 363-374.
81. Toyokuni S. (1999). Reactive oxygen species-induced molecular damage and its application in pathology. Pathol. Internat. 49, 91-102.
82. Turchan J., Pocernich C.B., Gairola C., Chauhan A., Schiffito G., Butterfield D.A., Buch S., Narayan O., Sinai A., Geiger J., Berger J.R., Elford H. and Nath A. (2003). Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60, 307-314.
83. Tyler K.L. (2001). Mammalian reoviruses. In: Fields virology. Knipe DM, Howley PM (eds). Lippincott, Philadelphia, pp 1729-1745.
84. Tyler K.L. and Nathanson N. (2001). Pathogenesis of viral infections. In: Fields virology. Knipe D.M. amd Howley P.M. (eds). Lippincott, Philadelphia. pp 199-243.
85. Tyler K.L, Barton E.S., Ibach M.L., Robinson .C, Campbell J.A., O'Donnell S.M., Valyi-Nagy T., Clarke P., Wetzel J.D. and Dermody T.S. (2004). Isolation and characterization of a novel type 3 reovirus from a child with meningitis. J. Infect. Dis. 189, 1664-1675.
86. Tyler K.L., McPhee D.A. and Fields B.N. (1986). Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science 233, 770-774.
87. Uchida K., Itakura K., Kawakishi S., Hiai H., Toyokuni S. and Stadtman ER. (1995). Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch. Biochem. Biophys. 324, 241-248.
88. Valyi-Nagy T., Olson S.J., Valyi-Nagy K., Montine T.J. and Dermody T.S (2000). Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology 278, 309-321.
89. Valyi-Nagy T., Sidell K., Marnett L.J., Dermody T., Roberts L.J., Morrow J.D. and Montine T.J. (1999). Divergence of brain prostaglandin H synthetase activity and oxidative damage in mice with encephalitis. J Neuropathol. Exp. Neurol. 58, 1269-1272.
90. Viviani B., Corsini E., Binaglia M., Galli C.L. and Martinovich M. (2001). Reactive oxygen species generated by glia are responsible for neuron death induced by human immunodeficiency virus-glycoprotein 120 in vitro. Neuroscience 107, 51-58.
91. Walsch K.A., Megyesi J.F., Wilson J.X, Crukley J., Laubach V.E. and Hammond R.R. (2004). Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity. J. Neuroinflammation 27, 1-8.
92. Weiner H.L., Drayna D., Averill D.R. and Fields B.N. (1977). Molecular basis of reovirus virulence: role of the S1 gene. Proc. Natl. Acad. Sci. USA 74, 5744-5748.
93. Weiner H.L., Powers M.L. and Fields B.N. (1980). Absolute linkage of virulence and central nervous system cell tropism of reoviruses to hemagglutinin. J. Infect. Dis. 141, 609-616.
94. Weis S., Haug H. and Budka H. (1993). Neural damage in the cerebral cortex of AIDS brains: a morphometric study. Acta Neuropathol. 85, 185-189.
95. Wesselingh S.L., Power C., Glass J.D., Tyor W.R., McArthur J.C., Farber J.M., Griffin J.W. and Griffin D.E. (1993). Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33, 576-582.
96. Whitley R.J. (2001). Herpes simplex viruses. In: Fields virology. Knipe D.M and Howley P.M (eds). Lippincott Raven Press. Philadelphia. pp 2461-2510.
97. Wilt S.G., Dugger N.V., Hitt N.D. and Hoffman P.M. (2000). Evidence of oxidative damage in a murine leukemia virus-induced neurodegeneration. J. Neurosci. Res. 62, 440-450.
98. Yin B., Whyatt R.M., Perera F.P., Randall M.C., Cooper T.B. and Santella R.M. (1995). Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Rad. Biol. Med. 18, 1023-1032.
99. Yolken R. (2004). Viruses and schizophrenia: focus on herpes simplex virus. Herpes 2, 83A-88A.
100. Zaragoza C., Ocampo C.J., Saura M., Bao C., Leppo M., Lafond-Walker A., Thiemann D.R., Hruban R. and Lowenstein C.J. (1999). Inducible nitric oxide synthase protection against coxsackievirus pneumonitis. J. Immunol. 163, 5497-5504.